Bringing the fundamentals into focus…
Back to Amneal Pharmaceuticals, Inc.
How Amneal Pharmaceuticals, Inc. stacks up
AMRX · against 199 other Healthcare companies of similar size
Overall
57/ 100
Above the middle of the pack.
Ranked #96 of 200 · scores higher than 50% of peers
Bars: peers in each 10-point band of the overall score50 peers with an overall score of 50–59, including AMRX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around AMRX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 37.3B HKD (≈$4.8B) | 90 | 99 | 98 | 84 | 0 / 2 | |
| 2 | 921.9B INR (≈$11.1B) | 82 | 84 | 80 | 94 | 0 / 2 | |
| 3 | 936.1B JPY (≈$6.4B) | 80 | 65 | 86 | 94 | 0 / 2 | |
| 4 | 40.3B SEK (≈$4.0B) | 79 | 43 | 84 | 97 | 0 / 2 | |
| 5 | 10.7B USD | 78 | 77 | 85 | 84 | 0 / 2 | |
| 90 | 11.6B USD | 58 | 94 | 61 | 57 | 2 / 2 | |
| 90 | 596.9B INR (≈$7.2B) | 58 | 47 | 70 | 72 | 1 / 2 | |
| 90 | 3.9B USD | 58 | 68 | 51 | 71 | 1 / 2 | |
| 96 | 26.6B CNY (≈$3.7B) | 57 | 91 | 40 | 55 | 1 / 2 | |
| 96 | 7.0B USD | 57 | 62 | 89 | 72 | 2 / 2 | |
| 96 | 9.0B USD | 57 | 69 | 46 | 71 | 1 / 2 | |
| 96 | 11.6B USD | 57 | 92 | 50 | 81 | 2 / 2 | |
| 96 | 69.1B BRL (≈$12.4B) | 57 | 78 | 59 | 61 | 2 / 2 | |
| 101 | 52.2B HKD (≈$6.7B) | 56 | 99 | 32 | 59 | 1 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score